Interpace Diagnostics Group, Inc. Exchange Agreements
6 Contracts & Agreements
- Exchange Agreement, dated as of October 10, 2024, by and among Interpace Biosciences, Inc., 1315 Capital II, L.P. and Ampersand 2018 Limited Partnership (Filed With SEC on October 15, 2024)
- Form of Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock (included as Exhibit A to the Securities Purchase and Exchange... (Filed With SEC on January 14, 2020)
- AMENDMENT AND EXCHANGE AGREEMENT (Filed With SEC on April 18, 2017)
- EXCHANGE AGREEMENT (Filed With SEC on March 23, 2017)
- Portions of this exhibit were omitted and filed separately with the Secretary of the Securities and Exchange Commission pursuant to an application for confidential treatment filed... (Filed With SEC on November 5, 2014)
- Portions of this exhibit were omitted and filed separately with the Secretary of the Securities and Exchange Commission pursuant to an application for confidential treatment filed... (Filed With SEC on November 13, 2013)
